![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, March 19, 2022 10:01:05 PM
The FOURTH Clot Shot, is proof this is NOT WORKING and we need AVIPTADIL AND OR ZYESAMI. ~ posted by Joe Kaplan @ iHub
https://rumble.com/vxeqvu-pathologist-on-ryan-cole-on-the-mystery-blood-clots.html
We need ZYESAMI/AVIPTADIL/RFL-100 now!!
Dear Dr. Califf and Dr. Fauci:
We are writing regarding a recent report of a physician practicing in Texas who has used a treatment—ZYESAMI—under the Right to Try Act to save COVID-19 patients’ lives.[1] Our understanding is the drug manufacturer, NRx Pharmaceuticals, applied for three Emergency Use Authorization’s (EUA) with the Food and Drug Administration (FDA) for ZYESAMI. NRx submitted its most recent EUA application on January 4, 2022 but the FDA has not yet granted this authorization. However, we are told the FDA refuses to review the data until the completion of clinical trials later this year.[2] We write to request information on the FDA’s review of ZYESAMI, as well as other information about treatment options for Americans suffering from COVID-19.
According to the physician, more than 20 patients suffering respiratory failure from COVID-19 received ZYESAMI as authorized under Right to Try.[3] At the end of the letter, we included the stories of three individuals that credit ZYESAMI with saving their lives. It is our understanding the patients received ZYESAMI after prior administration of remdesivir did not improve the patients’ conditions.[4] All the patients were at the very end stage of COVID and were not expected to recover. Upon receiving ZYESAMI, no serious adverse events associated with use were reported and 16 of the 20 patients left the hospital.[5] According to the physician, patients with ARDS normally have a 40 percent mortality rate.[6] With ZYESAMI, the mortality rate decreased to roughly 10 percent.[7]
.
.
.
https://www.wispolitics.com/2022/u-s-sen-johnson-leads-colleagues-in-demanding-answers-from-dr-califf-and-dr-fauci/
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM